Extend your brand profile by curating daily news.

AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

By Burstable Editorial Team

TL;DR

AAA Biotech's expansion of recombinant proteins offers researchers a competitive edge by providing high-quality, versatile tools for groundbreaking biomedical research.

AAA Biotech delivers recombinant proteins with over 95% purity, utilizing various expression systems and rigorous QC to ensure reliability for scientific experiments.

By supplying high-quality recombinant proteins, AAA Biotech accelerates life sciences research, paving the way for medical breakthroughs that improve global health.

Discover how AAA Biotech's recombinant proteins, with their high purity and flexibility, are revolutionizing experiments in life sciences today.

Found this article helpful?

Share it with your network and spread the knowledge!

AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

AAA Biotech has announced the expansion of its recombinant proteins (rProteins) portfolio, reinforcing its position as a global leader in providing high-quality research reagents for the life sciences sector. This development is set to significantly impact biomedical research by offering scientists and researchers access to a broader range of tools for their experiments.

The company's recombinant proteins are engineered through precise genetic methods, with target genes expressed in active systems such as E. coli, mammalian cells (HEK293, CHO), yeast, and insect cells. These proteins are crucial for a wide array of applications, including protein-protein and protein-DNA interactions, functional biological assays, and drug discovery processes. AAA Biotech ensures the highest standards of quality, with purities typically exceeding 95%, validated through affinity chromatography procedures.

Key features of AAA Biotech's rProteins include high purity and activity, with the majority of proteins guaranteed to be 95% pure and tested for bioactivity. The proteins can be expressed in various systems to accommodate different research needs, including folding, post-translational modifications, and functionality. Additionally, the company offers flexibility in custom expressions and tags, catering to the specific requirements of diverse experiments.

Quality control is a paramount concern for AAA Biotech, with products undergoing rigorous testing and analysis, including SDS-PAGE, endotoxin testing, and activity assays. Each batch comes with a Certificate of Analysis, ensuring researchers have all the necessary documentation for their work. The proteins are available in user-friendly formats, such as lyophilized or ready-to-use liquid forms, facilitating easy storage and handling.

This expansion of AAA Biotech's recombinant proteins portfolio is a testament to the company's commitment to supporting the life sciences community. By providing high-quality, versatile research reagents, AAA Biotech is enabling researchers to push the boundaries of scientific discovery. For more information, visit https://www.aaabiotech.com/.

Curated from 24-7 Press Release

blockchain registration record for this content
Burstable Editorial Team

Burstable Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.